Jennifer Lagoutte-Renosi

9PUBLICATIONS
31CO-AUTHORS
PharmacogenomicsMedical molecular engineering of nucleic acids and proteinsBiomedical engineering not elsewhere classifiedGene and molecular therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Apr 28, 2026
Machine Learning in HIV Care and Antiretroviral Therapy: Systematic Review.

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|Jul 17, 2024
Ticagrelor increases its own potency at the P2Y12 receptor by directly changing the plasma membrane lipid order in platelets.

Kyrylo Pyrshev, Florentin Allemand, Vahideh Rabani

|Jun 28, 2021
Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants.

Jennifer Lagoutte-Renosi, Mylène Flammang, Didier Ducloux

|Feb 12, 2021
Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite.

Jennifer Lagoutte-Renosi, Florentin Allemand, Christophe Ramseyer

Pageof 2

Frequent Collaborators

5 joint publications

Siamak Davani

2 joint publications

Alexandre Destere

2 joint publications

Sébastien Lalanne

2 joint publications

Matthieu Grégoire